InvestorX
SEDAR® Issuer number:
00047392
Company name:
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation)
Document type:
Report of exempt distribution excluding schedule 1 of Form 5
Project number:
06065438
Filing date:
12-20-2023